References
- Jenner FA, Pollitt RJ. Large quantities of 2-acetamido-1-(beta-L-aspartamido)-1,2-dideoxyglucose in the urine of mentally retarded siblings. Biochem J 1967; 103: 48P–49P
- Arvio P, Arvio M. Progressive nature of aspartylglucosaminuria. Acta Paediatr 2002; 91: 255–7
- Pollit R, Pretty K. The glycoasparagines in urine of patient with aspartylglucosaminuria. Biochem J 1974; 151: 141–6
- AJ Barkovich. Pediatric neuroimaging. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 18.
- Autti T, Raininko R, Haltia M, Lauronen L, Vanhanen SL, Salonen O, et al. Aspartylglucosaminuria: radiologic course of the disease with histopathologic correlation. J Child Neurol 1997; 12: 369–75
- Tenhunen K, Uusitalo A, Autti T., Joensuu R, Kettunen M, Kauppinen RA, et al. Monitoring the CNS pathology in aspartylglucosaminuria mice. J Neuropathol Exp Neurol 1998; 5: 1154–63
- Autti T, Santavuori P, Raininko R, Renlund M, Rapola J, Saarinen-Pihkala U. Bone-marrow transplantation in aspartylglucosaminuria. Lancet 1997; 349: 1336–7
- Autti T, Rapola J, Santavuori P, Raininko R, Renlund M, Liukkonen E, et al. Bone marrow transplantation in aspartylglucosaminuria – histopathological and MRI study. Neuropediatrics 1999; 30: 293–8
- Malm G, Månsson JE, Winiarski J, Mosskin M, Ringden O. Five-years follow-up of two siblings with aspartylglucosaminuria undergoing allogeneic stem-cell transplantation from unrelated donors. Transplantation 2004; 78: 415–9
- Arvio M, Sauna-Aho O, Peippo M. Bone marrow transplantation for aspartylglucosaminuria: follow-up study of transplanted and non-transplanted patients. J Pediatr 2001; 138: 288–90
- Autti T, Raininko R, Vanhanen S-L, Kallio M, Santavuori P. MRI of the normal brain from early childhood to middle age. I. Appearances on T2- and proton density-weighted images and occurrence of incidental high-signal foci. Neuroradiology 1994; 36: 649–51
- Autti T, Raininko R, Vanhanen S-L, Kallio M, Santavuori P. MRI of the normal brain from early childhood to middle age. II. Age dependence of signal intensity changes on T2-weighted images. Neuroradiology 1994; 36: 649–51
- Collie DA, Summers DM, Sellar RJ, Ironside JW, Cooper S, Zeidler M, et al. Diagnosing variant Creutzfeldt-Jacob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. Am J Neuroradiol 2003; 24: 1560–9
- Moore DF, Ye F, Schiffmann R, Butman JA. Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease. Am J Neuroradiol 2003; 24: 1096–101
- Takanashi J, Barkovich AJ, Dillon WP, Sherr EH, Hart KA, Packman S. T1 hyperintensity in the pulvinar: key imaging feature for diagnosis of Fabry disease. Am J Neuroradiol 2003; 24: 916–21
- Tabira T, Goto I, Kuroiwa Y, Kikuchi M. Neuropathological studies in Fabry's disease. Acta Neuropathol 1974; 30: 345–54
- Haltia M, Palo J, Autio S. Aspartylglucosaminuria: a generalized storage disease. Morphological and histochemical studies. Acta Neuropathol (Berl) 1975; 31: 243–55
- Autti T, Joensuu R, Åberg L. Decreased T2 signal in the thalami may be a sign of lysosomal storage disease. Neuroradiology 2007; 49: 571–8